Neurological Implications of COVID-19 Infections

The magnitude of the COVID-19 pandemic will result in substantial neurological disease, whether through direct infection (rare), para-infectious complications (less rare), or critical illness more generally (common). Here, we raise the importance of stringent diagnosis and data collection regarding...

Full description

Saved in:
Bibliographic Details
Published in:Neurocritical care Vol. 32; no. 3; pp. 667 - 671
Main Authors: Needham, Edward J., Chou, Sherry H.-Y., Coles, Alasdair J., Menon, David K.
Format: Journal Article
Language:English
Published: New York Springer US 01.06.2020
Springer Nature B.V
Subjects:
Betacoronavirus
Biomarkers
Brain research
Cognitive Dysfunction - etiology
Conflicts of interest
Consent
Coronavirus Infections - complications
Coronavirus Infections - physiopathology
COVID-19
Critical Care
Critical Care Medicine
Critical Illness
Cross Infection - prevention & control
Data Collection
Disease
Encephalitis
Encephalomyelitis
Encephalomyelitis, Acute Disseminated - etiology
Epidemics
Guillain-Barre syndrome
Guillain-Barre Syndrome - etiology
Humans
Illnesses
Immunosuppressive Agents - adverse effects
Infection Control
Infections
Intensive
Internal Medicine
International Cooperation
Longitudinal studies
Medical laboratories
Medicine
Medicine & Public Health
Mortality
Myelitis, Transverse - etiology
Nervous System Diseases - drug therapy
Nervous System Diseases - etiology
Nervous System Diseases - physiopathology
Neurology
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - physiopathology
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Viewpoint
COVID-19
Encephalitis
Guillain–Barré syndrome
Acute disseminated encephalomyelitis
ISSN:1541-6933, 1556-0961, 1556-0961
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The magnitude of the COVID-19 pandemic will result in substantial neurological disease, whether through direct infection (rare), para-infectious complications (less rare), or critical illness more generally (common). Here, we raise the importance of stringent diagnosis and data collection regarding neurological complications of COVID-19; we urge caution in the over-diagnosis of neurological disease where it does not exist, but equally strongly encourage the concerted surveillance for such conditions. Additional to the direct neurological complications of COVID-19 infection, neurological patients are at risk of harm from both structural limitations (such as number of intensive care beds), and a hesitancy to treat with certain necessary medications given risk of nosocomial COVID-19 infection. We therefore also outline the specific management of patients with neuroinflammatory diseases in the context of the pandemic. This article describes the implications of COVID-19 on neurological disease and advertises the Neurocritical Care Society’s international data collection collaborative that seeks to align data elements.
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:1541-6933
1556-0961
1556-0961
DOI:10.1007/s12028-020-00978-4